世界のバイオマーカー検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biomarker Test Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0805
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、バイオマーカー検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（がん、心血管、感染症、中枢神経系（CNS））、用途別市場規模（製薬・バイオテクノロジー企業、診断ツール企業、医療IT/ビッグデータ企業、臨床検査室）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・バイオマーカー検査の市場動向
・企業の競争状況、市場シェア
・バイオマーカー検査の種類別市場規模（がん、心血管、感染症、中枢神経系（CNS））
・バイオマーカー検査の用途別市場規模（製薬・バイオテクノロジー企業、診断ツール企業、医療IT/ビッグデータ企業、臨床検査室）
・バイオマーカー検査の北米市場規模2016-2027（アメリカ、カナダ）
・バイオマーカー検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・バイオマーカー検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・バイオマーカー検査の中南米市場規模2016-2027（メキシコ、ブラジル）
・バイオマーカー検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（F. Hoffmann-La Roche、Novartis、PFIZER、GlaxoSmithKline、GE Healthcare、Medtronics、Quest Diagnostics）
・結論

Most healthcare experts use analysis assessments to make clear and aid their scientific choice making. Steadily over latest years, the analytic manner has turned out to be more potent by means of the need to preselect sufferers in mild of medicines and licenses. This flow has come to through various factors, which include propelling generation (empowering specialists to degree more particular markers of adequacy), an elevated comprehension of the disease manner, and a more outstanding electricity approximately the individuality of an individual’s tumor at the molecular degree.

Market Analysis and Insights: Global Biomarker Test Market
The global Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biomarker Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biomarker Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biomarker Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biomarker Test market.

Global Biomarker Test Scope and Market Size
Biomarker Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biomarker Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cancer
Cardiovascular
Infectious Diseases
Central Nervous System

Segment by Application
Pharma & Biotech Companies
Diagnostic tool companies
Healthcare IT/Big data companies
Clinical laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche
Novartis
PFIZER
GlaxoSmithKline
GE Healthcare
Medtronics
Quest Diagnostics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer
1.2.3 Cardiovascular
1.2.4 Infectious Diseases
1.2.5 Central Nervous System
1.3 Market by Application
1.3.1 Global Biomarker Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharma & Biotech Companies
1.3.3 Diagnostic tool companies
1.3.4 Healthcare IT/Big data companies
1.3.5 Clinical laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biomarker Test Market Perspective (2016-2027)
2.2 Biomarker Test Growth Trends by Regions
2.2.1 Biomarker Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biomarker Test Historic Market Share by Regions (2016-2021)
2.2.3 Biomarker Test Forecasted Market Size by Regions (2022-2027)
2.3 Biomarker Test Industry Dynamic
2.3.1 Biomarker Test Market Trends
2.3.2 Biomarker Test Market Drivers
2.3.3 Biomarker Test Market Challenges
2.3.4 Biomarker Test Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biomarker Test Players by Revenue
3.1.1 Global Top Biomarker Test Players by Revenue (2016-2021)
3.1.2 Global Biomarker Test Revenue Market Share by Players (2016-2021)
3.2 Global Biomarker Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biomarker Test Revenue
3.4 Global Biomarker Test Market Concentration Ratio
3.4.1 Global Biomarker Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Test Revenue in 2020
3.5 Biomarker Test Key Players Head office and Area Served
3.6 Key Players Biomarker Test Product Solution and Service
3.7 Date of Enter into Biomarker Test Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biomarker Test Breakdown Data by Type
4.1 Global Biomarker Test Historic Market Size by Type (2016-2021)
4.2 Global Biomarker Test Forecasted Market Size by Type (2022-2027)

5 Biomarker Test Breakdown Data by Application
5.1 Global Biomarker Test Historic Market Size by Application (2016-2021)
5.2 Global Biomarker Test Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biomarker Test Market Size (2016-2027)
6.2 North America Biomarker Test Market Size by Type
6.2.1 North America Biomarker Test Market Size by Type (2016-2021)
6.2.2 North America Biomarker Test Market Size by Type (2022-2027)
6.2.3 North America Biomarker Test Market Size by Type (2016-2027)
6.3 North America Biomarker Test Market Size by Application
6.3.1 North America Biomarker Test Market Size by Application (2016-2021)
6.3.2 North America Biomarker Test Market Size by Application (2022-2027)
6.3.3 North America Biomarker Test Market Size by Application (2016-2027)
6.4 North America Biomarker Test Market Size by Country
6.4.1 North America Biomarker Test Market Size by Country (2016-2021)
6.4.2 North America Biomarker Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Biomarker Test Market Size (2016-2027)
7.2 Europe Biomarker Test Market Size by Type
7.2.1 Europe Biomarker Test Market Size by Type (2016-2021)
7.2.2 Europe Biomarker Test Market Size by Type (2022-2027)
7.2.3 Europe Biomarker Test Market Size by Type (2016-2027)
7.3 Europe Biomarker Test Market Size by Application
7.3.1 Europe Biomarker Test Market Size by Application (2016-2021)
7.3.2 Europe Biomarker Test Market Size by Application (2022-2027)
7.3.3 Europe Biomarker Test Market Size by Application (2016-2027)
7.4 Europe Biomarker Test Market Size by Country
7.4.1 Europe Biomarker Test Market Size by Country (2016-2021)
7.4.2 Europe Biomarker Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biomarker Test Market Size (2016-2027)
8.2 Asia-Pacific Biomarker Test Market Size by Type
8.2.1 Asia-Pacific Biomarker Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biomarker Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biomarker Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Biomarker Test Market Size by Application
8.3.1 Asia-Pacific Biomarker Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biomarker Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biomarker Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Biomarker Test Market Size by Region
8.4.1 Asia-Pacific Biomarker Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biomarker Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biomarker Test Market Size (2016-2027)
9.2 Latin America Biomarker Test Market Size by Type
9.2.1 Latin America Biomarker Test Market Size by Type (2016-2021)
9.2.2 Latin America Biomarker Test Market Size by Type (2022-2027)
9.2.3 Latin America Biomarker Test Market Size by Type (2016-2027)
9.3 Latin America Biomarker Test Market Size by Application
9.3.1 Latin America Biomarker Test Market Size by Application (2016-2021)
9.3.2 Latin America Biomarker Test Market Size by Application (2022-2027)
9.3.3 Latin America Biomarker Test Market Size by Application (2016-2027)
9.4 Latin America Biomarker Test Market Size by Country
9.4.1 Latin America Biomarker Test Market Size by Country (2016-2021)
9.4.2 Latin America Biomarker Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biomarker Test Market Size (2016-2027)
10.2 Middle East & Africa Biomarker Test Market Size by Type
10.2.1 Middle East & Africa Biomarker Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biomarker Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biomarker Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Biomarker Test Market Size by Application
10.3.1 Middle East & Africa Biomarker Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biomarker Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biomarker Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Biomarker Test Market Size by Country
10.4.1 Middle East & Africa Biomarker Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biomarker Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Biomarker Test Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Biomarker Test Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Biomarker Test Introduction
11.2.4 Novartis Revenue in Biomarker Test Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 PFIZER
11.3.1 PFIZER Company Details
11.3.2 PFIZER Business Overview
11.3.3 PFIZER Biomarker Test Introduction
11.3.4 PFIZER Revenue in Biomarker Test Business (2016-2021)
11.3.5 PFIZER Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Biomarker Test Introduction
11.4.4 GlaxoSmithKline Revenue in Biomarker Test Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Biomarker Test Introduction
11.5.4 GE Healthcare Revenue in Biomarker Test Business (2016-2021)
11.5.5 GE Healthcare Recent Development
11.6 Medtronics
11.6.1 Medtronics Company Details
11.6.2 Medtronics Business Overview
11.6.3 Medtronics Biomarker Test Introduction
11.6.4 Medtronics Revenue in Biomarker Test Business (2016-2021)
11.6.5 Medtronics Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Details
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Biomarker Test Introduction
11.7.4 Quest Diagnostics Revenue in Biomarker Test Business (2016-2021)
11.7.5 Quest Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biomarker Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cancer
Table 3. Key Players of Cardiovascular
Table 4. Key Players of Infectious Diseases
Table 5. Key Players of Central Nervous System
Table 6. Global Biomarker Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biomarker Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Biomarker Test Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Biomarker Test Market Share by Regions (2016-2021)
Table 10. Global Biomarker Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Biomarker Test Market Share by Regions (2022-2027)
Table 12. Biomarker Test Market Trends
Table 13. Biomarker Test Market Drivers
Table 14. Biomarker Test Market Challenges
Table 15. Biomarker Test Market Restraints
Table 16. Global Biomarker Test Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Biomarker Test Market Share by Players (2016-2021)
Table 18. Global Top Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Test as of 2020)
Table 19. Ranking of Global Top Biomarker Test Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Biomarker Test Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Biomarker Test Product Solution and Service
Table 23. Date of Enter into Biomarker Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biomarker Test Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Biomarker Test Revenue Market Share by Type (2016-2021)
Table 27. Global Biomarker Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Biomarker Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Biomarker Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Biomarker Test Revenue Market Share by Application (2016-2021)
Table 31. Global Biomarker Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Biomarker Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Biomarker Test Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Biomarker Test Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Biomarker Test Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Biomarker Test Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Biomarker Test Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Biomarker Test Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Biomarker Test Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Biomarker Test Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Biomarker Test Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Biomarker Test Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Biomarker Test Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Biomarker Test Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biomarker Test Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biomarker Test Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biomarker Test Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Biomarker Test Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biomarker Test Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Biomarker Test Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Biomarker Test Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Biomarker Test Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Biomarker Test Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Biomarker Test Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Biomarker Test Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Biomarker Test Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biomarker Test Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biomarker Test Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biomarker Test Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Biomarker Test Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biomarker Test Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Biomarker Test Market Size by Country (2022-2027) & (US$ Million)
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Biomarker Test Product
Table 66. F. Hoffmann-La Roche Revenue in Biomarker Test Business (2016-2021) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Biomarker Test Product
Table 71. Novartis Revenue in Biomarker Test Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. PFIZER Company Details
Table 74. PFIZER Business Overview
Table 75. PFIZER Biomarker Test Product
Table 76. PFIZER Revenue in Biomarker Test Business (2016-2021) & (US$ Million)
Table 77. PFIZER Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Biomarker Test Product
Table 81. GlaxoSmithKline Revenue in Biomarker Test Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. GE Healthcare Company Details
Table 84. GE Healthcare Business Overview
Table 85. GE Healthcare Biomarker Test Product
Table 86. GE Healthcare Revenue in Biomarker Test Business (2016-2021) & (US$ Million)
Table 87. GE Healthcare Recent Development
Table 88. Medtronics Company Details
Table 89. Medtronics Business Overview
Table 90. Medtronics Biomarker Test Product
Table 91. Medtronics Revenue in Biomarker Test Business (2016-2021) & (US$ Million)
Table 92. Medtronics Recent Development
Table 93. Quest Diagnostics Company Details
Table 94. Quest Diagnostics Business Overview
Table 95. Quest Diagnostics Biomarker Test Product
Table 96. Quest Diagnostics Revenue in Biomarker Test Business (2016-2021) & (US$ Million)
Table 97. Quest Diagnostics Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biomarker Test Market Share by Type: 2020 VS 2027
Figure 2. Cancer Features
Figure 3. Cardiovascular Features
Figure 4. Infectious Diseases Features
Figure 5. Central Nervous System Features
Figure 6. Global Biomarker Test Market Share by Application: 2020 VS 2027
Figure 7. Pharma & Biotech Companies Case Studies
Figure 8. Diagnostic tool companies Case Studies
Figure 9. Healthcare IT/Big data companies Case Studies
Figure 10. Clinical laboratories Case Studies
Figure 11. Biomarker Test Report Years Considered
Figure 12. Global Biomarker Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Biomarker Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Biomarker Test Market Share by Regions: 2020 VS 2027
Figure 15. Global Biomarker Test Market Share by Regions (2022-2027)
Figure 16. Global Biomarker Test Market Share by Players in 2020
Figure 17. Global Top Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Test as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Biomarker Test Revenue in 2020
Figure 19. Global Biomarker Test Revenue Market Share by Type (2016-2021)
Figure 20. Global Biomarker Test Revenue Market Share by Type (2022-2027)
Figure 21. North America Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Biomarker Test Market Share by Type (2016-2027)
Figure 23. North America Biomarker Test Market Share by Application (2016-2027)
Figure 24. North America Biomarker Test Market Share by Country (2016-2027)
Figure 25. United States Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Biomarker Test Market Share by Type (2016-2027)
Figure 29. Europe Biomarker Test Market Share by Application (2016-2027)
Figure 30. Europe Biomarker Test Market Share by Country (2016-2027)
Figure 31. Germany Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Biomarker Test Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Biomarker Test Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Biomarker Test Market Share by Region (2016-2027)
Figure 41. China Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Biomarker Test Market Share by Type (2016-2027)
Figure 49. Latin America Biomarker Test Market Share by Application (2016-2027)
Figure 50. Latin America Biomarker Test Market Share by Country (2016-2027)
Figure 51. Mexico Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Biomarker Test Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Biomarker Test Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Biomarker Test Market Share by Country (2016-2027)
Figure 57. Turkey Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Biomarker Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Biomarker Test Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Biomarker Test Business (2016-2021)
Figure 62. PFIZER Revenue Growth Rate in Biomarker Test Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Biomarker Test Business (2016-2021)
Figure 64. GE Healthcare Revenue Growth Rate in Biomarker Test Business (2016-2021)
Figure 65. Medtronics Revenue Growth Rate in Biomarker Test Business (2016-2021)
Figure 66. Quest Diagnostics Revenue Growth Rate in Biomarker Test Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の腫瘍バイオマーカー検査市場規模・現状・予測（2021年-2027年）

Global Tumor Biomarker Test Market Size, Status and Forecast 2021-2027
QYR2104Z5756 2021年4月 95Pages
QYResearch社発行の本調査資料では、腫瘍バイオマーカー検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（前立腺特異抗原検査、CTC検査、α-フェトプロテイン（AFP）検査、CA検査、HER2検査、BRCA検査、未分化リンパ腫キナーゼ（...

世界のバイオマーカー市場規模・現状・予測（2021年-2027年）

Global Biomarker Market Size, Status and Forecast 2021-2027
QYR2104Z0804 2021年4月 93Pages
QYResearch社発行の本調査資料では、バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、サービス）、用途別市場規模（診断開発、創薬・開発、疾病リスク）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のバイオマーカー検査市場 2021：企業別、地域別、種類・用途別

Global Biomarker Test Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z02221 2021年4月 108Pages
当調査資料では、バイオマーカー検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオマーカー検査の種類別市場規模（がん、心血管、感染症、中枢神経系）、用途別市場規模（製薬・バイオテクノロジー産業、診断ツール産業、医療IT /ビッグデータ産業、臨床検...

世界の診断バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Diagnostic Biomarker Market Size, Status and Forecast 2021-2027
QYR2104Z1843 2021年4月 97Pages
QYResearch社発行の本調査資料では、診断バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（S100、MART-1、Gp100、HMB45、AFP、BCR-ABL、その他）、用途別市場規模（病院、がん研究機関、診断研究所）、主...

世界の前立腺がんバイオマーカー市場規模・現状・予測（2021年-2027年）

Global Prostate Cancer Biomarker Market Size, Status and Forecast 2021-2027
QYR2104Z4827 2021年4月 97Pages
QYResearch社発行の本調査資料では、前立腺がんバイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（尿、血、血清）、用途別市場規模（病院、診療所、がん研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界のメタボロミクスバイオマーカー市場規模・現状・予測（2021年-2027年）

Global Metabolomics Biomarker Market Size, Status and Forecast 2021-2027
QYR2104Z3718 2021年4月 93Pages
QYResearch社発行の本調査資料では、メタボロミクスバイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンパク質マーカー、核酸マーカー）、用途別市場規模（毒物学的研究、薬物検査、癌、心血管障害、神経障害、先天性代謝異常症）、主...

世界のリキッドバイオプシー用循環バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Circulating Biomarker for Liquid Biopsy Market Size, Status and Forecast 2021-2027
QYR2104Z1336 2021年4月 95Pages
QYResearch社発行の本調査資料では、リキッドバイオプシー用循環バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他）、...

世界の代謝バイオマーカー検査市場規模・現状・予測（2021年-2027年）

Global Metabolic Biomarker Testing Market Size, Status and Forecast 2021-2027
QYR2104Z3712 2021年4月 96Pages
QYResearch社発行の本調査資料では、代謝バイオマーカー検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（分離技術、検出技術、その他）、用途別市場規模（創薬、ニュートリゲノミクス、毒物学検査、個別化医療、機能ゲノミクス、その他）、主要地...

世界のボーカルバイオマーカー市場規模・現状・予測（2021年-2027年）

Global Vocal Biomarker Market Size, Status and Forecast 2021-2027
QYR2104Z5960 2021年4月 97Pages
QYResearch社発行の本調査資料では、ボーカルバイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（周波数、振幅、エラー率、発声時間、ピッチ、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のゲノムバイオマーカー市場規模・現状・予測（2021年-2027年）

Global Genomic Biomarker Market Size, Status and Forecast 2021-2027
QYR2104Z2543 2021年4月 133Pages
QYResearch社発行の本調査資料では、ゲノムバイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンパク質マーカー、核酸マーカー、その他）、用途別市場規模（病院、診断・研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界のバイオマーカー検査市場 2021：企業別、地域別、種類・用途別 The Biomarker Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
世界の腫瘍バイオマーカー検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の診断バイオマーカー市場規模・現状・予測（2021年-2027年） Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various pur…
世界の中枢神経系（CNS）バイオマーカー市場規模・現状・予測（2021年-2027年） With extensive ongoing development in personalized medicines and the application of biomarkers in diagnosis, the complexity of the central nervous system paves way for the development of biomarkers to enhance early diagnosis of neurological disorders such as Alzheimer's disease, Parkinson's disease,…
世界の前立腺がんバイオマーカー市場規模・現状・予測（2021年-2027年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. Market Analysis and Insights: Global Prostate Cancer Biomarker Market The gl…